Acupressure Mat on Perceived Stress, Sleep Quality and Premenstrual Symptoms

NCT06644365 | Not Yet Recruiting

• 1 other identifier: 2024
• Study Type: interventional
• Target: 42
• Locations: 0 countries
• Sites: N/A

Brief Summary

Purpose of the study: To examine the effect of acupressure mat on perceived stress, sleep quality and premenstrual symptoms in students with premenstrual syndrome. Hypotheses of the study; In the post-test and follow-up test between students who were applied acupressure mat and those who were applied plain mat; H10: There is no difference in terms of severity of premenstrual symptoms. H20: There is no difference in terms of perceived stress. H30: There is no difference in terms of sleep quality.

Conditions

Premenstrual Symptoms; Effect of Acupressure Mat

Outcome Measures

Primary Outcomes (3)

• Premenstrual Syndrome Symptom Scale

  It was developed by Gençdoğan (2006) to measure the severity of premenstrual symptoms. The scale consists of 44 questions that measure the severity of premenstrual symptoms based on DSM-III and DSM-IV-R. It is a five-point Likert-type scale. In the scoring of the scale, the option "Never" is given 1 point, the option "Very little" is given 2 points, and the option "Sometimes" is given 3 points.

  just before the application starts (pre-test), 12 weeks after the application starts (after the application ends/post-test) and 16 weeks later (follow-up test).

• Perceived Stress Scale

  The scale was developed by Cohen et al. in 1983 to measure the stress a person perceives in a given situation and was adapted to Turkish by Eskin et al. (2013). The 5-point Likert-type scale (Never (0)-Very often (4)) contains a total of 14 items. 7 items with positive expressions are scored in reverse. The minimum score from 0 to a maximum of 56 points can be obtained from the scale. A high score indicates that the person is highly stressed.

  just before the application starts (pre-test), 12 weeks after the application starts (after the application ends/post-test) and 16 weeks later (follow-up test).

• Visual Analog Scale (VAS) Sleep Quality

  Students will be asked to evaluate their sleep quality with the Visual Analog Scale. VAS-sleep quality is a 10 cm long tool. "My sleep quality is very poor" is written on the left end of the scale and "My sleep quality is very good" is written on the right. A score of 10 from the scale indicates that sleep quality is high, while a score of 0 indicates that sleep quality is very poor.

  just before the application starts (pre-test), 12 weeks after the application starts (after the application ends/post-test) and 16 weeks later (follow-up test).

Study Arms (2)

control group

PLACEBO COMPARATOR

Students will be given a placebo exercise on a flat yoga/exercise mat on the same days, in the same way and for the same duration as the intervention group.

Other: Basic mat

intervention group

EXPERIMENTAL

They will be asked to lie on the acupressure mat for 15 minutes once a day, 3 days a week (Monday, Wednesday, Friday). A reminder message will be sent on the morning of the application so that participants do not forget and are motivated. After each application, participants will be asked to fill out the session monitoring chart.

Other: Acupresure mat

Interventions

Acupresure mat OTHER

The Premenstrual Syndrome Scale will be applied and the scale results will be evaluated. Participants who score 132 and above on the scale will be considered to be experiencing PMS. The intervention will be made in the second phase of the study.This practice will continue for three menstrual cycles.

intervention group

Basic mat OTHER

The Premenstrual Syndrome Scale will be applied and the scale results will be evaluated. Participants who score 132 and above on the scale will be considered to be experiencing PMS. The intervention will be made in the second phase of the study.Participants in this group will also be sent a reminder message similar to the intervention group. This practice will continue for three menstrual cycles.

control group

Eligibility Criteria

• Sex: female
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Using medication and/or non-medical methods to cope with PMS
• Having any gynecological disease (abnormal uterine bleeding, myoma, ovarian cyst, etc.)
• Using contraceptive medication.

You may not qualify if:

• Participants wanting to withdraw from the study at any stage of the study
• Participants not complying with the research plan
• Diagnosed with a psychiatric or gynecological disease during the study
• Participants starting to receive additional treatment for PMS during the study period

Sponsors & Collaborators

• Gulhane School of Medicine: lead

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Asist. Prof.

Study Record Dates

• First Submitted: October 13, 2024
• First Posted: October 16, 2024
• Study Start: November 15, 2024
• Primary Completion: November 30, 2024
• Study Completion: March 30, 2025
• Last Updated: October 16, 2024

Record last verified: 2024-10